Biotechnology
United Health Products Awaits FDA Decision on Hemostatic Gauze Clinical Study
United Health Products, Inc. is in the process of addressing FDA findings related to a BIMO audit for its hemostatic gauze product, CelluSTAT, aiming to expedite patient enrollment upon approval.
CNS Pharmaceuticals Inc. to Showcase Glioblastoma Treatment Advancements at Brain Tumor Biotech Summit
CNS Pharmaceuticals Inc. will present promising data on its brain-penetrating taxane candidate, TPI 287, at the upcoming Brain Tumor Biotech Summit, highlighting potential breakthroughs in treating glioblastoma and other CNS tumors.
Telomir Pharmaceuticals Reports Preclinical Breakthrough in Age-Reversal with Telomir-1
Telomir Pharmaceuticals' preclinical results for Telomir-1 show promising age-reversal effects in a zebrafish model of Werner Syndrome, highlighting potential advancements in longevity science.
Orca Bio Strengthens Leadership Team with Key Appointments Ahead of Potential Commercial Launch
Orca Bio has appointed Steve Gavel as Chief Commercial Officer and Allison Frisbee as Senior Vice President, Legal, marking a strategic move to bolster its leadership team as it prepares for the potential commercial launch of its lead investigational therapy, Orca-T®.
Bio-Path Holdings Advances in RNAi Therapeutics with Promising Clinical Trials
Bio-Path Holdings, Inc. makes strides in RNA interference therapeutics, with its DNAbilize® platform showing potential in treating cancers, obesity, and type 2 diabetes, marking a significant step forward in biotechnology.
Repertoire Immune Medicines Strengthens Leadership with Appointment of Dr. Robert Andtbacka as Chief Medical Officer
Repertoire Immune Medicines appoints Dr. Robert Andtbacka as Chief Medical Officer, marking a significant step in advancing its pipeline of T cell-targeted therapies for cancer and autoimmune diseases.
Jean Witz Joins Wilson Sonsini as Senior Patent Counsel, Bolstering Firm's Expertise in Biotechnology and Pharmaceuticals
Jean Witz, with nearly 40 years of experience in patent law and a distinguished career at the USPTO, joins Wilson Sonsini as senior patent counsel, enhancing the firm's capabilities in biotechnology, pharmaceuticals, and chemical engineering.
Lorati Unveils NanoClay Paste: A Natural Revolution in Wound Care
Lorati Company Limited introduces NanoClay Paste, a natural, mineral-based treatment offering fast and effective healing for chronic wounds and skin infections, marking a significant advancement in non-invasive medical solutions.
Telomir Pharmaceuticals Advances Telomere-Targeting Drug, Seeks Strategic Partnerships
Telomir Pharmaceuticals is preparing to submit an Investigational New Drug (IND) application for Telomir-1, a potential breakthrough small molecule targeting aging mechanisms, with plans to explore strategic collaborations at the BIO International Convention 2025.
Molecular 'Velcro' Breakthrough Promises Advanced Drug Delivery and Biosensing Technologies
Researchers introduce a novel supramolecular chemistry concept called controllable ultrahigh-affinity molecular recognition (CUAMR), which offers unprecedented control in molecular interactions with potential transformative applications in biotechnology and medicine.
Neuroscientists Develop RADICAL: A Breakthrough Tool for Precise Neural Control
Researchers have engineered a novel chemogenetic tool called RADICAL that enables non-invasive, precise manipulation of brain activity using a synthetic chemical, offering significant potential for neuroscience research and therapeutic interventions.
Telomir Pharmaceuticals Reveals Promising Vision Restoration in Preclinical AMD Study
Telomir Pharmaceuticals has demonstrated its oral therapeutic candidate Telomir-1 can restore vision and reverse retinal degeneration in a zebrafish model of age-related macular degeneration, highlighting potential breakthrough treatment for vision loss.
Alzamend Neuro Launches Phase II Trial for Innovative Lithium-Based Alzheimer's Therapy
Alzamend Neuro has initiated a Phase II clinical trial for AL001, a novel lithium therapy targeting multiple neuropsychiatric conditions, with potential to improve brain drug delivery and reduce side effects.
RNA Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has appointed Dr. Phillip D. Zamore, a leading RNAi researcher, to its Scientific Advisory Board, potentially strengthening the company's oncology research capabilities and RNA therapeutic development strategies.
Breakthrough Stem Cell Dog Chews Show Promising Results in Veterinary Trials
Bioadaptives Inc's PawPa division has developed Regen Dog Chews that demonstrate significant potential for improving canine health through natural stem cell stimulation, with clinical trials showing a dramatic increase in circulating stem cells.
RNAi Pioneer Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics has added renowned RNA biology expert Dr. Phillip D. Zamore to its Scientific Advisory Board, potentially strengthening the company's RNA-targeted cancer therapy research and development strategy.
RNAi Pioneer Dr. Phillip Zamore Joins TransCode Therapeutics' Scientific Advisory Board
TransCode Therapeutics strengthens its scientific leadership by appointing renowned RNA interference expert Dr. Phillip Zamore to its Scientific Advisory Board, potentially boosting the company's cancer therapeutic research capabilities.
NanoViricides Reveals Breakthrough Antiviral Platform at BIO International Convention
NanoViricides will showcase its novel NV-387 broad-spectrum antiviral drug candidate, which demonstrates promising preclinical efficacy against multiple viral infections, potentially revolutionizing viral treatment approaches.
Oragenics Implements 1-for-30 Reverse Stock Split to Enhance Market Appeal
Biotechnology company Oragenics will execute a reverse stock split to improve its capital markets positioning and potentially attract long-term investors, consolidating 30 existing shares into one new share.
FDA Updates COVID-19 Vaccination Strategy, GeoVax Poised to Meet Targeted Needs
The FDA has shifted to a risk-based COVID-19 vaccination approach, prioritizing protection for vulnerable populations. GeoVax's multi-antigen vaccine GEO-CM04S1 appears well-positioned to address these evolving public health requirements.
CD BioSciences Advances Aging Research with Customizable Mouse Models
CD BioSciences has developed highly customizable mouse models for aging research, offering pharmaceutical and biotech companies precision tools to accelerate drug discovery and understand age-related diseases more effectively.
Soligenix Develops Novel Therapy to Address Antibiotic-Resistant Bacterial Infections
Soligenix's SGX943 represents a potential breakthrough in combating antibiotic-resistant bacteria, offering a novel broad-spectrum therapy that could help address a critical public health challenge.
Intelligent Bio Solutions Advances Non-Invasive Drug Testing Technology for U.S. Market
Intelligent Bio Solutions is progressing toward FDA clearance for a groundbreaking fingerprint-based drug screening system with 94.1% accuracy, positioning the company for potential expansion across safety-critical industries in the United States.
Creative Biolabs Expands CAR-T Therapy Development with Comprehensive CDMO Services
Creative Biolabs is offering end-to-end solutions for CAR-T therapy development, providing comprehensive services from plasmid design to viral vector manufacturing, potentially accelerating personalized cancer treatment research.
Calidi Biotherapeutics Unveils Promising Cancer Therapy Platform RTNova
Calidi Biotherapeutics has developed RTNova, an innovative gene therapy platform targeting tumors with minimal damage to healthy tissues, potentially revolutionizing cancer treatment approaches.
Creative Biolabs Advances Exosome Research with Enhanced Platform Capabilities
Creative Biolabs has upgraded its Extracellular Vesicle platform, offering more precise exosome isolation, characterization, and RNA sequencing techniques that could accelerate disease research and diagnostic capabilities.
Telomir Pharmaceuticals Secures $3M Investment to Advance Age-Reversal Research
Telomir Pharmaceuticals has received a strategic $3 million equity investment from The Bayshore Trust, bolstering its efforts to develop potential breakthrough therapies targeting age-related diseases and longevity.
Biotech Startup Lionheart Health Advances in $101M XPRIZE Healthspan Competition
Lionheart Health has been selected as one of 40 semi-finalists in a global competition aimed at developing treatments to dramatically extend healthy human aging. The company's innovative bioelectric signaling technology could potentially restore multiple age-related declines in just one year.
Creative Biolabs Advances Lactobacillus Research with Comprehensive Probiotic Development Services
Creative Biolabs launches advanced Lactobacillus development solutions, offering comprehensive screening, validation, and engineering services for probiotic research. The company's multi-dimensional approach aims to enhance understanding of microbiome interactions and potential therapeutic applications.
Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials
Quantum BioPharma has signed an agreement with a contract research organization to prepare an Investigational New Drug application for Lucid-21-302, a potential breakthrough therapy for multiple sclerosis that could prevent neurological damage.